The American Journal of Managed Care

Subcutaneous Ocrelizumab and Hyaluronidase Approved for RMS, PPMS

Ocrelizumab and hyaluronidase is now the first and only twice-yearly subcutaneous injection approved for relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The ...
The American Journal of Managed Care

Daratumumab and Hyaluronidase-fihj–Based Quadruplet Regimen Approved in MM

Daratumumab/hyaluronidase-fihj plus bortezomib, lenalidomide, and dexamethasone is now approved by the FDA to treat newly diagnosed multiple myeloma (MM) in patients ...
Seeking Alpha

argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
Healio

Keep hyaluronidase on hand to address injection filler complications

Please provide your email address to receive an email when new articles are posted on . KOLOA, Hawaii — Hypersensitivity reactions to injection fillers are rare and unpredictable, but when they occur, ...
Monthly Prescribing Reference

Efgartigimod Alfa–Hyaluronidase Improves Ocular Myasthenia Gravis Symptoms

Findings showed patients treated with efgartigimod alfa–hyaluronidase achieved a statistically significant improvement in MGII PRO ocular scores vs placebo at week 4. Topline data were announced from ...
Seeking Alpha

FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Builds on RYBREVANT FASPRO™ FDA approval to deliver the simplest and fastest combination regimen for EGFR+ non-small cell lung cancer 1,3-6 HORSHAM, Pa., Feb. 17, 2026 /PRNewswire/ -- Johnson & ...
MedPage Today

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

The FDA approved subcutaneous daratumumab-hyaluronidase (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (VRd) for induction and consolidation in ...
Pharmabiz

US FDA approves Janssen Biotech’s teclistamab in combo with daratumumab hyaluronidase-fihj, Tec-Dara under the National Priority Voucher Programme

Silver Spring, Maryland Saturday, March 7, 2026, 11:00 Hrs [IST] ...
Medscape

Hyaluronidase Speeds Up Insulin Absorption From Skin

October 9, 2012 (Berlin, Germany) — In a randomized, double-blind, comparator-controlled, 2-way crossover trial, 2 rapid-acting insulin analogs (lispro or aspart) formulated with recombinant human ...